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Predominant synthesis of IgA with lambda light chain in IgA nephrop-
athy. The nature of the light chains in mesangial IgA deposits and serum
IgA was studied in patients with IgA nephropathy. Immunofluores-
cence (IF) studies using murine monoclonal antibodies, rabbit and goat
anti-human monospecific antisera were performed in kidney sections
from 15 IgA nephritic patients with only IgA isotype detected in the
renal biopsy. Lambda light chain IF was demonstrated in all biopsy
specimens and kappa light chain IF in 11 renal biopsy specimens. The
majority of renal biopsies showed a predominance of lambda light chain
IF staining in the mesangial deposits. The concentration of individual
immunoglobulins and their light chain fractions, and the kappa/lambda
ratio were determined in the serum and the supernate from peripheral
blood mononuclear cells culture of 30 IgA nephritic patients and 30
age-matched healthy controls. The IgA nephritic patients had a higher
serum concentration of total IgA (P cc 0.001) and a significantly lower
IgA kappa/lambda ratio (P cc 0.001) compared with the controls, The
kappa/lambda ratio of supernatant IgA from IgA nephritic patients (N =
20) was also significantly lower than that of the normal subjects (N =
14), both in the unstimulated (P cc 0.01) and pokeweed mitogen
stimulated, peripheral blood mononuclear-cell culture (P cc 0.05). Our
results showed that patients with primary IgA nephropathy displayed a
unique immunologic response characterized by a predominance of IgA
with lambda light chain in circulation.
Primary IgA nephropathy characterized by mesnngial depo-
sition of IgA and C3 commonly occurs in young subjects with
synpharyngitic hematuria [1]. This entity of glomerulonephritis
has now been recognized to be the most common glomerulop-
athy in many countries [1—3].
IgA is present in the circulation as monomeric units, mainly
of the Al subclass, but at mucosnl sites it is secreted actively as
Al or A2 dimers polymerized by J-chain and transported by
binding to the secretory component [4]. Normal serum IgA
contains approximately 90% IgAl and 10% IgA2 [5]. Recent
reports demonstrate that the glomerular IgA deposits consist
predominantly of monomeric IgAl with a minor proportion of
IgA2 [6—8]. These findings suggest that the circulating IgA
immune complex is deposited in the glomeruli of patients with
IgA nephropathy irrespective of antibody subclass. Contrary to
the IgAl and IgA2 subclasses, our preliminary data suggest that
predominant lambda light chain immunofluorescence (IF) oc-
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curs in the mesangial immunoglobulin deposits in IgA nephrop-
athy [9], despite the fact that the normal ratio of kappa to
lambda light chain immunoglobulin in human sera is approxi-
mately two to one [10]. Since the light chain IF may arise from
the concomitant mesangial 1gM and IgG deposits, one could
argue that a definitive immunochemical characterization of the
light chains in the mesangial IgA deposits in IgA nephropathy
could be difficult. The present study was undertaken to confirm
our previous finding in renal tissues and to determine the
kappallambda light chain ratio of different immunoglobulins in
serum and lymphocyte culture supernate from normal subjects
and patients with IgA nephropathy.
Methods
Patients
A total of 15 percutaneous renal biopsy specimens from 15
patients with primary IgA nephropathy were studied. IgA
nephropathy was diagnosed on the basis of the following
pathologic criterion: focal or diffuse segmental mesangial pro-
liferative glomerulonephritis on light microscopy; presence of
predominant IgA deposits, mainly in the mesangium in immu-
nofluorescence studies; and presence of electron dense deposits
in the mesangium and paramesangial areas on ultrastructural
examination [3]. These 15 kidney biopsies showed IgA deposits
alone and formed the basis of our histopathologic studies.
Systemic lupus erythematosus, Henoch-SchOnlein purpura, and
hepatic diseases were excluded by clinical and laboratory
examinations. Renal tissue from 15 patients who died suddenly
from trauma and other causes where postmortem examinations
failed to reveal neoplastic, hepatic, autoimmune, or renal
diseases were used as control.
An additional 15 patients with biopsy-proven IgA nephrop-
athy were included in the studies of light chain ratio in serum
immunoglobulins and 30 age-matched medical and nursing
personnels acted as controls. The studies of immunoglobulins in
serum and lymphocyte culture supernate were performed dur-
ing an infection-free and clinical quiescent period.
Immunofluorescence studies
Renal biopsy specimens which demonstrated mesangial IgA
deposits alone were examined by (a) direct immunofluores-
cence costained with 1:10 rhodamine-conjugated goat anti-
human alpha heavy chain (F(ab')2 fragments) (Tago, Burling-
ame, California, USA) and 1:15 FITC-labeled rabbit anti-human
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lambda or kappa light chain (F(ab')2 fragments) (Dakopatts,
Copenhagen, Denmark); (b) direct immunofluorescence with
1:15 FITC-labeled goat anti-human lambda and kappa light
chains (F(ab')2 fragments) (Tago); and (c) indirect immunoflu-
orescence with 1:15 murine monoclonal antibody against hu-
man lambda light chain and 1:75 murine monoclonal antibody
against human kappa light chain (Becton-Dickinson, Mountain
View, California, USA) followed by 1:10 FITC conjugated goat
anti-mouse immunoglobulins (Coulter, Hialeah, Florida, USA).
The slides were examined with a coded basis by two observers
(F.M.L. and K.N.L.) under ultraviolet illumination, with an
Orthoplan microscope equipped with a Ploem illuminator (Leitz,
Heidelberg, FRG). The fluorescence intensity of the slide
preparations was visually scored semiquantitatively as 0, 1+,
2+, 3+ and 4+ by two observers without the knowledge of
previous immunofluorescence studies and the nature of anti-
human light chain antisera.
The costained sections were examined in a fluorescence
microscope with epiilumination equipped with filters for nar-
row-band excitation and barrier filters LP515 for fluorescein
and LP580 for rhodamine visualization. Alternated immunoflu-
orescence examination was permitted by switching one filter
consecutively to the other. Photographs were taken on standard
Kodacolor film developed at 100 ASA.
Antisera
The properties and specificities of fluorescein-conjugated
(FITC) rabbit anti-human lambda and kappa chain antisera
(Dakopatts) had been tested as described in our previous
communication [91. Briefly, the antisera were purified by gel
filtration and ion exchange chromatography. Their monospeci-
ficity was ascertained by Ouchterlony double immunodiffusion
in agarose gel against Bence-Jones lambda and kappa chain,
purified by gel filtration and immunoadsorplion chromatogra-
phy (Behringwerke AG, Marburg, FRG and our laboratory).
The monospecificity of the goat anti-human lambda and kappa
light chains, F(ab')2 fragments, antisera (Tago) and murine
monoclonal antibodies against human lambda and kappa light
chains (Becton-Dickinson) were similarly ascertained. These
antibodies had been further tested not to show any cross
reactions using fresh, human lymphoid tissue. The molar fluo-
rescein/protein ratios of the rabbit anti-human lambda and
kappa light chain antisera were identical: 2.30. The molar
fluorescein/protein ratio of goat anti-human lambda chain anti-
serum was 2.50, and this ratio was lower than the value of 3.08
for the goat anti-human kappa chain antiserum. The antibody
concentrations of the antibodies were determined by radial
immunodiffusion by the supplier. The antibody concentrations
of the rabbit anti-human antisera were identical (100 jsg/ml), but
the antibody concentration of the goat anti-human kappa anti-
serum (0.7 mg/mI) was slightly higher than that of lambda
antiserum (0.6 mg/mI). The kappa and lambda monoclonal
antibody concentration was 125 sg/ml and 25 jsg/ml, respec-
tively.
Lymphocyte culture and in vitro immunoglobulin production
Peripheral blood mononuclear cells. (PBMC) were separated
from heparinized whole blood by density gradient centrifuga-
tion using Ficoll Hypaque (Nyegaard, Oslo, Norway). After
three washes in TC-199 (Gibco, Chargrin Falls, Ohio, USA),
the cells were resuspended at a concentration of 1 x 106 cells/ml
in complete culture medium (CCM) consisting of RPMI 1640
(Gibco) supplemented with 10% heat-inactivated fetal calf se-
rum, 2 mt L-glutamine, 100 U/ml penicillin, 100 sg/ml strep-
tomycin and 2.5 ig/ml fungizone. One hundred p1 aliquots of
this cell suspension were dispensed into 96-well microculture
flat-bottom plastic plates (Costar, Cambridge, Massachusetts,
USA) and cultured in quadruplicates without mitogen and with
pokeweed mitogen (PWM) (Sigma Chemicals, St. Louis, Mis-
souri, USA) at a concentration of 1 jsg/ml. The PBMC were
incubated at 37°C in humid atmosphere of 5% CO2 in air. The
cell free supemates prepared from the lymphocyte cultures on
the fifth day were stored at —40°C until assayed.
Assay of immuno globulins and determination of
kappa/lambda ratios
IgA, IgG and 1gM in lymphocyte culture supernates were
quantitated by enzyme-linked immunosorbent assay (ELISA).
Purified immunoglobulin fractions of specific rabbit antisera to
human a, y and s chains (Dakopatts) were used at 1:2000
dilution. Microtiter plates (Labsystems OY, Helsinki, Finland)
were coated by adding 100 p1/well of the appropriate antiserum
diluted in 0.015 M sodium carbonate-bicarbonate buffer, pH 9.6.
The plates were incubated overnight at 4°C and washed 20 times
with phosphate buffer saline, pH 7.4, containing 0.05% (vol/vol)
Tween 20 (PBS-tween). Samples and immunoglobulin stan-
dards (Dakopatts) appropriately diluted in CCM were then
introduced, 100 p1/well in duplicate. After incubation at 37°C
for three hours, the plates were again washed 20 times with
PBS-tween. The same antisera as used for coating, but conju-
gated with horseradish peroxidase and diluted 1:2000 in PBS-
tween, were added, 100 p1/well as appropriate. Incubation at
37°C was continued for another two hours and the washing
repeated. A freshly prepared substrate solution containing 10
mg urea hydrogen peroxide and 35 mg o-phenylene-diamine
dihydrochloride (Sigma Chemicals) in 50 ml 0.20 M phosphate-
citrate buffer, pH 5.0, was then added, 100 p1/well, and the
plates incubated at 37°C for a further 30 minutes. Finally, the
reaction was terminated by addition of 50 p1/well of 0.10 M citric
acid, pH 3.0, and the absorbances were measured at 450 nm
wavelength using a Dynatech MR 600 Microplate Reader (Dy-
natech Laboratories Inc., Alexandria, Virginia, USA). Immu-
noglobulin concentrations were determined by reference to
their respective standard curves.
Kappa/lambda light chain ratios of immunoglobulins in sera
and lymphocyte culture supernates were determined also by
ELISA. Working standards were prepared from a commercial
human serum standard (Behringwerke AG) with known overall
kappa and lambda chain concentrations, using CCM as diluent.
Employing the same procedure as for the immunoglobulin
assay, antibodies to a, y, and chains immobilized on micro-
titer plates were used to capture the respective immunoglob-
ulins in these working standards, and 1:500 diluted peroxidase-
conjugated anti-kappa and anti-lambda sera (Dakopatts) were
used for quantitation of light chains on the captured immuno-
globulins. By calculation of absorbance ratios, the kappa and
lambda chain concentrations of individual immunoglobulins in
the standard were determined, and the kappa/lambda ratios
computed. The reliability of such further calibration was coun-
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Table 1. Frequency of presence of each light chain immunofluorescence and its intensity in the mesangial deposits of 15 patients with IgA
nephropathy
Antisera
Kappa positive Lambda positive Intensity of fluorescencea lambda/kappa
ratioIgA (alpha) lambda kappanumber of patients
Rahhit anti-human (direct IF) 12 15 43 38 15 2.53
Got anti-human (direct IF) 11 15 44 38 14 2.71
Murine monoclonal (indirect IF) 11 15 not done 29 10 2,90
a The fluorescence scores were obtained by addition of the points from renal biopsy of individual patient, on a scale of zero to four.
Fig. 1. Costained IF of heavy and light chains in a patient with IgA nephropathy. (A) FITC rabbit anti-human lambda IF (3+), (B)
Rhodamine-conjugated goat anti-human alpha IF (2+) in the same section as (a), and (C) FITC rabbit anti-human kappa IF (2+) in a serial deeper
section. (magnification x 430).
terchecked with IgA, IgG and 1gM standards (Dakopatts), the
kappa/lambda ratios of which have been determined by ELISA
of individual immunoglobulins containing only one light chain
type after the other type had been removed by anti-kappa or
anti-lambda antibody coated on microtiter plates.
Test samples were appropriately diluted and assayed using
the now calibrated standard and the same ELISA.
Serum immuno globulin concentration
This was assayed by the rate of immunonephelometry using a
Beckman ICS-Il analyzer and reagents.
Statistics
The results are expressed as mean standard error of the
mean (saM), and Student's unpaired t-tests were used for
analysis of the data.
Results
Immunofluorescence studies
All 15 kidney biopsies were positive for mesangial IgA
deposits as revealed by polyclonal antibodies, but neither IgG
nor 1gM was detected in the mesangium or the glomerular
capillary basement membrane. The frequency with which de-
posits of lambda and kappa light chain were detected in the
renal biopsies with different antisera is shown in Table 1. All 15
renal biopsy specimens (100%) showed mesangial lambda light
chain IF, and 11(73%) showed mesangial kappa light chain IF.
The mesangial IF pattern of lambda and kappa light chains was
similar to those of the alpha heavy chain when the renal
biopsies were costained with the double immunofluorescence
technique (Fig. 1). These IF findings confirmed that the light
chain IF came directly from the mesangial IgA deposits, as
there was no concomitant deposition of IgG or 1gM in these
glomeruli. Neither IgA, IgG, 1gM, or two subclasses of light
chain was found in any of the 15 control biopsy specimens.
The intensity of mesangial immunofluorescence is depicted in
Table 1. With the use of three different sources of kappa and
lambda light chain antisera at comparable antibody concentra-
tion, the fluorescence intensity score for lambda light chain was
at least one to two points higher than that of kappa light chain
in 13 patients, while the remaining two showed similar IF score.
The IF scores for IgA, lambda and kappa light chains from
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direct immunofluorescence using rabbit or goat antisera were
similar, but lower IF scores were generally obtained in indirect
IF studies using monoclonal antibodies.
Serum studies
The serum concentrations of individual immunoglobulins and
their light chain fractions are present in Figure 2. Patients with
IgA nephropathy had a significantly higher serum concentration
of total IgA, kappa light chain IgA, and lambda light chain IgA
when compared with healthy controls. The IgA kappa/lambda
ratio was 0.91 0.03 in IgA nephrotic patients, and this was
significantly lower than the value of 1.20 0.05 measured in
normal subjects (P < 0.001). These findings indicated a predom-
inance of lambda light chain containing IgA in the serum of
patients with IgA nephropathy. No correlation was found
between the total serum IgA and the kappa/lambda ratio in
individual patients (r = 0.1768, not significant).
0 0
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IgA IgA IgA IgA
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The serum IgG and 1gM concentrations of the IgA nephritic
patients were comparable to those of the normal subjects.
Despite a different kappa/lambda ratio detected between the
patients and the normal controls, the serum concentrations of
kappa chain 1gM and kappa chain IgG were nevertheless higher
than those of lambda chain 1gM and IgG in both patients and
controls.
Lymphocyte culture supernates studies
The concentrations of individual immunoglobulins and their
light chain fractions are shown in Figure 3. There was no
difference observed in the numbers of B cells in the peripheral
blood mononuclear cell cultures from normal individuals and
patients with IgA nephropathy. The individual immunoglobulin
concentrations in supernate from the unstimulated (spontane-
ous) and the PWM-stimulated lymphocyte cultures were similar
in the patients and the normal subjects. The concentrations of
IgG, and 1gM in the supernate increased significantly when the
4
3
2
0
Total IgA Kappa-IgA Lambda-lgA IgA
kappa/lambda
ratio
4
3
2
Unstimulated PWM-stimulated
I,tIILj1
r
Total lgG Kappa-lgG Lambda-lgG lgG
kappa/lambda
ratio
20
0
Total lgG Lambda-
lgG lgG
Kappa- kappa/lambda
lgG ratio
0
Total 1gM Kappa-lgM Lambda-lgM 1gM
kappa/lambda
ratio
400 4
Unstimulated PWM-stimulated
3
Fig. 2. Serum studies of individual immunoglobulins and their light
chain fractions in patients with IgA nephropathy (U, N = 30) and
healthy controls (0, N = 30). The results are expressed as mean SaM.
* P < 0.001, ** P < 0.01.
Total 1gM Lambda-
1gM 1gM
Kappa- kappa/lambda
1gM ratIo
Fig. 3. Supernate studies of individual immunoglobulins and their light
chain fractions in patients with IgA nephropathy (U, N = 20) and
healthy controls (0, N = 14). The immunoglobulin concentration is
expressed as ng per 0.5 x 106 peripheral mononuclear cells. The results
are expressed as mean SEM. * P < 0.01, ** P <0.05.
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peripheral blood mononuclear cells from IgA nephritic patients
or controls were cultured with pokeweed mitogen (P < 0.01 for
IgG, and P < 0.05 for 1gM). Similarly, in vitro production of
IgA increased when the peripheral blood mononuclear cells
from the patients or the controls were stimulated with mitogen,
but these changes failed to reach statistical significance. The
mean concentration of lambda light chain IgA was higher than
that of the kappa light chain IgA in supernate obtained from
both the unstimulated and stimulated lymphocyte culture in
patients with IgA nephropathy. The kappa/lambda ratio of
supernatant IgA in patients was significantly lower than that of
normal subjects in both unstimulated (P < 0.01) and stimulated
lymphocyte cultures (P < 0.05). A significant difference of
kappa/lambda ratio in supernatant 1gM and IgG was not dem-
onstrated between the patients and the normal subjects.
Discussion
Our recent study demonstrated that predominant lambda
light chain IF staining occurred in glomerular immunoglobulin
deposits in primary IgA nephropathy and these findings inferred
that mesangial IgA deposits comprised predominantly lambda
chain IgA [9]. Fifty-eight percent of our previous renal biopsies
had concomitant mesangial 1gM and/or IgG deposits, and the
interpretation of the mesangial light chain IF could be difficult
as the light chain IF could arise from the IgG and 1gM deposits.
In the present study, we have repeated these immunofluores-
cence studies with three different antisera in renal tissues from
another 15 patients with mesangial IgA deposits alone to clarify
the immunochemical nature of the light chains of the mesangial
IgA deposits. Lambda light chain IgA was present in all 15
biopsy specimens and kappa light chain IgA was demonstrated
in 73% of the biopsy specimens. Although our measurement of
fluorescence was only semiquantitative, it was apparent that the
lambda IF was either equal to or stronger than the kappa IF in
most renal biopsies studied with rabbit anti-human antisera.
More meaningful was the fact that similar results were obtained
in studies with goat anti-human light chain antisera in which the
antibody concentration and fluorescein/protein ratio were higher
for the kappa chain antiserum. The IF patterns observed with
murine monoclonal antibodies were similar to those of polyclo-
nal antisera despite a less sensitive detection with monoclonal
antibodies than polyclonal antibodies [11]. The higher incidence
of positivity and the greater intensity of lambda light chain IF
over kappa light chain confirm our original observation that the
glomerular IgA deposits in IgA nephropathy are composed
predominantly of lambda light chain IgA.
This observation in the nature of the light chains in IgA
deposits in IgA nephropathy has an interesting bearing on the
immunopathogenesis of primary IgA nephropathy. As inferred
from the findings of glomerular and circulating IgAl and IgA2
subclasses [6—8], predominant kappa chain IgA deposits should
be expected as kappa chain immunoglobulin is the predominant
immunoglobulin fraction in serum of normal subjects [10]. Our
findings of predominant lambda light chain IgA deposits in
glomerular mesangium could indicate that the deposition of
circulating immune complexes in IgA nephropathy is highly
selective due to the differences in the multimeric nature, size of
the immune complexes and anionic charge of different sub-
classes of IgA [12]. The other possible immunopathologic
mechanism is the altered ratio of light chains with a given
specificity to an unidentified antigen leading to excessive pro-
duction of lambda light chain IgA.
The kappa/lambda ratio of individual immunoglobulins have
not been studied in detail in normal subjects or in disease. In
healthy subjects, the normal ratio of serum kappa chain to
lambda chain immunoglobulin is approximately two to one [10,
13, 14] and this ratio is obtained from either total serum (usually
predominantly IgG) or cord serum (containing only IgG). The
kappa/lambda ratio of IgG is confirmed in our normal subjects
and patients with IgA nephropathy. However, the kappa!
lambda ratio of serum IgA has not been studied previously. Our
present study demonstrates that the kappa/lambda ratios of IgA
and 1gM in normal subjects are significantly different from that
of IgG. Patients with IgA nephropathy have a higher serum
concentration of lambda chain IgA (P < 0.001) compared with
healthy controls. Furthermore, their kappa/lambda ratio of
serum IgA is significantly lower (P < 0.001). Nevertheless, a
predominance of serum kappa chain IgG and 1gM is demon-
strated in patients with IgA nephropathy as observed in con-
trols. These findings indicate that lambda chain IgA is the
predominant circulating IgA fraction in these patients. The
predominance of mesangial lambda IF is, therefore, mainly due
to a non-selective deposition of polyclonal IgA immune com-
plexes formed by a majority of lambda chain IgA.
In this study, we have further investigated the in vitro
production of immunoglobulin by cultured lymphocytes to
determine whether an altered antibody response is present in
patients with IgA nephropathy. Although other workers had
demonstrated a significant increase in in vitro production of IgA
by patients with IgA nephropathy [15—17], our results had
shown that the IgA production by peripheral blood mononu
clear cells was the same as that of the controls. Three other
studies had also failed to demonstrate an increase of in vitro
production of IgA in patients with igA nephropathy [18—201.
Inconsistencies in the IgA immune system abnormalities found
in IgA nephropathy may have some basis in methodological
variations, although a similar ELISA method has been used in
these studies. However, variability in patients selection and
study design may also contribute. It is important to note that in
the present study and the other two studies that failed to
demonstrate an increase of in vitro production of IgA [18, 191,
patients were examined in the quiescent phase of the disease
whereas the clinical status of patients reported by other studies
was not known [15—171. As observed by the other two groups of
investigators [18, 19], we have shown that the increase of in
vitro production of IgA with mitogen stimulation was insignif-
icant as compared with that of IgG or 1gM. These findings
suggest that the immunoregulatory function of lymphocytes
varies with the disease activity and these variations probably
contribute to the controversial findings in immune system
abnormalities in patients with IgA nephropathy, Although our
study of in vitro IgA production fails to demonstrate an IgA-
specific B cell hyperactivity as suggested by Hale and cowork-
ers [15], nevertheless, the immunoglobulin production by cul-
tured B cells from our patients during clinical quiescience is
quite specific as a significant quantity of lambda chain IgA in
response to an unidentified antigen was produced. The kap-
pa/lambda ratios of supernatant IgA obtained from both unstim-
ulated and stimulated cultures are significantly different from
Lai et al: Light chain in IgA nephropathy 589
those of healthy controls. Similar changes in supernatant IgG
and 1gM are not observed.
In conclusion, we have shown that mesangial IgA deposits in
primary IgA nephropathy consist mainly of IgA with lambda
light chain. These patients display a unique predominance of
circulating lambda chain IgA. The distinct reduction of kap-
pallambda ratio of IgA in serum and supernate from lymphocyte
culture strongly supports that IgA nephropathy is an immune
disorder with a specific antibody response.
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